Serum Metabolomic Profiles for Human Pancreatic Cancer Discrimination

This study evaluated the clinical use of serum metabolomics to discriminate malignant cancers including pancreatic cancer (PC) from malignant diseases, such as biliary tract cancer (BTC), intraductal papillary mucinous carcinoma (IPMC), and various benign pancreaticobiliary diseases. Capillary elect...

Descripción completa

Detalles Bibliográficos
Autores principales: Itoi, Takao, Sugimoto, Masahiro, Umeda, Junko, Sofuni, Atsushi, Tsuchiya, Takayoshi, Tsuji, Shujiro, Tanaka, Reina, Tonozuka, Ryosuke, Honjo, Mitsuyoshi, Moriyasu, Fuminori, Kasuya, Kazuhiko, Nagakawa, Yuichi, Abe, Yuta, Takano, Kimihiro, Kawachi, Shigeyuki, Shimazu, Motohide, Soga, Tomoyoshi, Tomita, Masaru, Sunamura, Makoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412351/
https://www.ncbi.nlm.nih.gov/pubmed/28375170
http://dx.doi.org/10.3390/ijms18040767

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5412351/
https://www.ncbi.nlm.nih.gov/pubmed/28375170
http://dx.doi.org/10.3390/ijms18040767

Ejemplares similares